These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21669212)

  • 41. Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.
    Nunes EJ; Randall PA; Hart EE; Freeland C; Yohn SE; Baqi Y; Müller CE; López-Cruz L; Correa M; Salamone JD
    J Neurosci; 2013 Dec; 33(49):19120-30. PubMed ID: 24305809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tetrabenazine, a vesicular monoamine transporter 2 inhibitor, inhibits vesicular storage capacity and release of monoamine transmitters in mouse brain tissue.
    Tod P; Varga A; Román V; Lendvai B; Pálkovács R; Sperlágh B; Vizi ES
    Br J Pharmacol; 2024 Sep; ():. PubMed ID: 39304979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methamphetamine administration reduces hippocampal vesicular monoamine transporter-2 uptake.
    Rau KS; Birdsall E; Volz TJ; Riordan JA; Baucum AJ; Adair BP; Bitter R; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2006 Aug; 318(2):676-82. PubMed ID: 16687477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Directed evolution reveals hidden properties of VMAT, a neurotransmitter transporter.
    Gros Y; Schuldiner S
    J Biol Chem; 2010 Feb; 285(7):5076-84. PubMed ID: 20007701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparing pharmacologic mechanism of action for the vesicular monoamine transporter 2 (VMAT2) inhibitors valbenazine and deutetrabenazine in treating tardive dyskinesia: does one have advantages over the other?
    Stahl SM
    CNS Spectr; 2018 Aug; 23(4):239-247. PubMed ID: 30160230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Specific derivatization of the vesicle monoamine transporter with novel carrier-free radioiodinated reserpine and tetrabenazine photoaffinity labels.
    Sievert MK; Hajipour AR; Ruoho AE
    Anal Biochem; 2007 Aug; 367(1):68-78. PubMed ID: 17559790
    [TBL] [Abstract][Full Text] [Related]  

  • 47. VMAT2 Inhibitors for Tardive Dyskinesia-Practice Implications.
    Peckham AM; Nicewonder JA
    J Pharm Pract; 2019 Aug; 32(4):450-457. PubMed ID: 29455579
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamine.
    Eyerman DJ; Yamamoto BK
    J Neurochem; 2007 Nov; 103(3):1219-27. PubMed ID: 17683483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluating depression and suicidality in tetrabenazine users with Huntington disease.
    Schultz JL; Killoran A; Nopoulos PC; Chabal CC; Moser DJ; Kamholz JA
    Neurology; 2018 Jul; 91(3):e202-e207. PubMed ID: 29925548
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes.
    Midde NM; Gomez AM; Zhu J
    J Neuroimmune Pharmacol; 2012 Sep; 7(3):629-39. PubMed ID: 22570010
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tetrabenazine-induced depletion of brain monoamines: characterization and interaction with selected antidepressants.
    Pettibone DJ; Totaro JA; Pflueger AB
    Eur J Pharmacol; 1984 Jul; 102(3-4):425-30. PubMed ID: 6489435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural mechanisms for VMAT2 inhibition by tetrabenazine.
    Dalton MP; Cheng MH; Bahar I; Coleman JA
    Elife; 2024 Mar; 12():. PubMed ID: 38517752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ketanserin and tetrabenazine abolish aggression in mice lacking monoamine oxidase A.
    Shih JC; Ridd MJ; Chen K; Meehan WP; Kung MP; Seif I; De Maeyer E
    Brain Res; 1999 Jul; 835(2):104-12. PubMed ID: 10415365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
    Chen JJ; Ondo WG; Dashtipour K; Swope DM
    Clin Ther; 2012 Jul; 34(7):1487-504. PubMed ID: 22749259
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure.
    McFadden LM; Vieira-Brock PL; Hanson GR; Fleckenstein AE
    Neuropharmacology; 2015 Jun; 93():146-54. PubMed ID: 25645392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of VMAT2 inhibitor GZ-793A on the reinstatement of methamphetamine-seeking in rats.
    Alvers KM; Beckmann JS; Zheng G; Crooks PA; Dwoskin LP; Bardo MT
    Psychopharmacology (Berl); 2012 Nov; 224(2):255-62. PubMed ID: 22638813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
    Hansen JP; Riddle EL; Sandoval V; Brown JM; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1093-100. PubMed ID: 11861820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. VMAT2 identified as a regulator of late-stage β-cell differentiation.
    Sakano D; Shiraki N; Kikawa K; Yamazoe T; Kataoka M; Umeda K; Araki K; Mao D; Matsumoto S; Nakagata N; Andersson O; Stainier D; Endo F; Kume K; Uesugi M; Kume S
    Nat Chem Biol; 2014 Feb; 10(2):141-8. PubMed ID: 24316738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tardive dyskinesia: placing vesicular monoamine transporter type 2 (VMAT2) inhibitors into clinical perspective.
    Citrome L
    Expert Rev Neurother; 2018 Apr; 18(4):323-332. PubMed ID: 29557243
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluoxetine Administration Exacerbates Oral Tremor and Striatal Dopamine Depletion in a Rodent Pharmacological Model of Parkinsonism.
    Podurgiel SJ; Milligan MN; Yohn SE; Purcell LJ; Contreras-Mora HM; Correa M; Salamone JD
    Neuropsychopharmacology; 2015 Aug; 40(9):2240-7. PubMed ID: 25759301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.